Filing Flows › Comparisons › TVTX vs VREOF
Travere Therapeutics vs Vireo Growth: TVTX and VREOF compared
Travere Therapeutics is the larger company: $225M of revenue in its latest quarter (Q3 2026) against $209M for Vireo Growth (Q2 2026). Vireo Growth is growing faster (+335% against +36% a year earlier). Vireo Growth is more profitable, with an operating margin of -3.0% against -30.3%.
Where the money goes: TVTX and VREOF
Travere Therapeutics (TVTX) · Q3 2026
Travere Therapeutics, Q3 2026: revenue $225M (+36% year over year), operating margin -30.3%, net loss $52.3M, operating cash flow $98.2M. The chart follows the revenue to costs, profit and cash.
Vireo Growth (VREOF) · Q2 2026
Vireo Growth, Q2 2026: revenue $209M (+335% year over year), operating margin -3.0%, net loss $100K, operating cash flow $2.4M. The chart follows the revenue to costs, profit and cash.
| Travere Therapeutics (TVTX) | Vireo Growth (VREOF) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $225M | $209M |
| Revenue growth, Y/Y | +36% | +335% |
| Operating margin | -30.3% | -3.0% |
| Net earnings | −$52.3M | −$100K |
| Net margin | -23.3% | 0.0% |
| Operating cash flow | $98.2M | $2.4M |
Where the revenue comes from
Travere Therapeutics
- Total net product sales: $220M (98%)
- License and collaboration revenue: $4.4M (2%)
Questions
Which is bigger, Travere Therapeutics or Vireo Growth?
Travere Therapeutics is the larger company: $225M of revenue in its latest quarter (Q3 2026) against $209M for Vireo Growth (Q2 2026).
Is Travere Therapeutics or Vireo Growth growing faster?
Vireo Growth is growing faster (+335% against +36% a year earlier).
Which is more profitable, Travere Therapeutics or Vireo Growth?
Vireo Growth is more profitable, with an operating margin of -3.0% against -30.3%.
More: Travere Therapeutics earnings · how Travere Therapeutics makes money · Vireo Growth earnings · how Vireo Growth makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.